| Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2 O Nosjean, M Ferro, F Cogé, P Beauverger, JM Henlin, F Lefoulon, ... Journal of Biological Chemistry 275 (40), 31311-31317, 2000 | 764 | 2000 |
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and … MJ Millan, L Maiofiss, D Cussac, V Audinot, JA Boutin, ... Journal of Pharmacology and Experimental Therapeutics 303 (2), 791-804, 2002 | 544 | 2002 |
| Myristoylation JA Boutin Cellular signalling 9 (1), 15-35, 1997 | 528 | 1997 |
| Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein ZC Dang, V Audinot, SE Papapoulos, JA Boutin, CWGM Löwik Journal of Biological Chemistry 278 (2), 962-967, 2003 | 427 | 2003 |
| Molecular tools to study melatonin pathways and actions JA Boutin, V Audinot, G Ferry, P Delagrange Trends in Pharmacological sciences 26 (8), 412-419, 2005 | 386 | 2005 |
| Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? R Jockers, P Maurice, JA Boutin, P Delagrange British journal of pharmacology 154 (6), 1182-1195, 2008 | 381 | 2008 |
| New selective ligands of human cloned melatonin MT1 and MT2 receptors V Audinot, F Mailliet, C Lahaye-Brasseur, A Bonnaud, A Le Gall, ... Naunyn-Schmiedeberg's archives of pharmacology 367, 553-561, 2003 | 324 | 2003 |
| Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation: up-regulated expression with adipocyte … G Ferry, E Tellier, A Try, S Grés, I Naime, MF Simon, M Rodriguez, ... Journal of Biological Chemistry 278 (20), 18162-18169, 2003 | 300 | 2003 |
| Comment on" Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake" N Chartrel, R Alvear-Perez, J Leprince, X Iturrioz, ARL Goazigo, V Audinot, ... science 315 (5813), 766-766, 2007 | 289 | 2007 |
| Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 O Nosjean, JP Nicolas, F Klupsch, P Delagrange, E Canet, JA Boutin Biochemical pharmacology 61 (11), 1369-1379, 2001 | 258 | 2001 |
| Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2‐adrenergic receptors (AR)s, serotonin (5‐HT)1A, 5‐HT1B, 5‐HT1D and dopamine D2 and D … MJ Millan, A Newman‐Tancredi, V Audinot, D Cussac, F Lejeune, ... Synapse 35 (2), 79-95, 2000 | 221 | 2000 |
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D2-like receptor and … A Newman-Tancredi, D Cussac, V Audinot, JP Nicolas, F De Ceuninck, ... Journal of Pharmacology and Experimental Therapeutics 303 (2), 805-814, 2002 | 210 | 2002 |
| Structure and expression of the human histamine H4-receptor gene F Cogé, SP Guénin, H Rique, JA Boutin, JP Galizzi Biochemical and biophysical research communications 284 (2), 301-309, 2001 | 206 | 2001 |
| Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-3-3-binding switch in melatonin synthesis S Ganguly, JA Gastel, JL Weller, C Schwartz, H Jaffe, MAA Namboodiri, ... Proceedings of the National Academy of Sciences 98 (14), 8083-8088, 2001 | 201 | 2001 |
| NRH: quinone reductase 2: an enzyme of surprises and mysteries F Vella, G Ferry, P Delagrange, JA Boutin Biochemical pharmacology 71 (1-2), 1-12, 2005 | 186 | 2005 |
| Genomic organization and characterization of splice variants of the human histamine H3 receptor F Coge, SP GUÉNIN, V AUDINOT, A RENOUARD-TRY, P BEAUVERGER, ... Biochemical Journal 355 (2), 279-288, 2001 | 179 | 2001 |
| New. alpha.-amino phosphonic acid derivatives of vinblastine: chemistry and antitumor activity G Lavielle, P Hautefaye, C Schaeffer, JA Boutin, CA Cudennec, A Pierre Journal of medicinal chemistry 34 (7), 1998-2003, 1991 | 178 | 1991 |
| Natural ligands of PPARγ:: Are prostaglandin J2 derivatives really playing the part? O Nosjean, JA Boutin Cellular signalling 14 (7), 573-583, 2002 | 177 | 2002 |
| Unraveling plant natural chemical diversity for drug discovery purposes E Lautie, O Russo, P Ducrot, JA Boutin Frontiers in pharmacology 11, 397, 2020 | 170 | 2020 |
| Characterization of the melatoninergic MT3 binding site on the NRH: quinone oxidoreductase 2 enzyme F Mailliet, G Ferry, F Vella, S Berger, F Cogé, P Chomarat, C Mallet, ... Biochemical pharmacology 71 (1-2), 74-88, 2005 | 169 | 2005 |
